JAMA Author Interviews: Covering research in medicine, science,& clinical practice. For physicians, researchers,& clinicians.

http://static.libsyn.com/p/assets/3/5/a/4/35a4af6f7d3f33ef/JAMA_AuthorInterview.png

Engaging and topical conversations with authors of research, clinical reviews, and opinion pieces published in JAMA. Subscribe for the latest information, ideas, and innovations in clinical medicine and health policy.

Website: http://jama.jamanetwork.com/multimedia.aspx#AuthorInterviews
Description: Engaging and topical conversations with authors of research, clinical reviews, and opinion pieces published in JAMA. Subscribe for the latest information, ideas, and innovations in clinical medicine and health policy.
Language: 🇬🇧 English
last modified: 2025-02-18 00:15
last episode published: 2025-02-17 16:00
publication frequency: 6.24 days
Contributors: The JAMA Network; Author; American Medical Association; Owner
Explicit: false
Number of Episodes: 848
Rss-Feeds: Detail page
Categories: Medicine Science & Medicine Health & Fitness

0 Likes 0 Followers 1 Subscribers

Sign up / Log in to like, follow, recommend and subscribe!

Recommendations

Episodes

Date	Title & Description	Contributors
2025-02-17	Evaluating Treatments for Amyotrophic Lateral Sclerosis The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 ...
2025-02-14	US Health Care Spending by Health Condition and County—What Drives Variation? Understanding health conditions with the most spending and variation across locations and over time is important for identifying trends, inequalities, and strategies for lowering health spending. Joseph Dieleman, PhD, of the University of Washington sp...
2025-02-13	Supporting Children and Families in an Era With Abortion Restrictions Two recent studies published in JAMA provide evidence about the effects of state-level abortion restrictions on birth rates and infant mortality. Author Alyssa Bilinski, PhD, MSc, of Brown University School of Public Health joins JAMA Deputy Editor Tra...
2025-01-29	Evaluating Comprehensive Models–Challenges and Innovations in Dementia Care Contemporary models of dementia care are multidisciplinary and aim to bridge medical and social services. Julie P. W. Bynum, MD, MPH, of the University of Michigan speaks with JAMA Deputy Editor Christopher C. Muth, MD, about 2 trials—the D-CARE and IN...
2025-01-13	Intra-Arterial Thrombolytics Following Thrombectomy for Ischemic Stroke Two new trials published in JAMA evaluate the efficacy of periprocedural intra-arterial thrombolytics after successful endovascular thrombectomy for patients with acute ischemic stroke. Diederik Dippel, MD, PhD, of Erasmus University Medical Center dis...
2025-01-09	Impact of Private Equity Acquisition on Patient Care Experience in US Hospitals Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of these acquisitions on patient experience. Author Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical Schoo...
2025-01-02	Asthma Endotypes Based on Nasal Epithelial Biopsies in School-Aged Youth Certain CD4+ T-cell subtypes play a role in asthma. Characterizing asthma endotypes in diverse groups is important to help develop effective therapies for youth with asthma. Author Juan C. Celedon, MD, DrPH, University of Pittsburgh, Department of Pedi...
2024-12-26	Dental Benefits and Medicare Advantage Plans Most Medicare Advantage (MA) plans offer dental care coverage as a supplemental benefit. However,few beneficiaries are enrolled in an MA plan that provides comprehensive dental benefits. Lisa Simon, MD, DMD, discusses this and more with JAMA Deputy Edi...
2024-12-18	2024 Update on Long COVID Classification and Symptom List Long COVID is now defined as a heterogeneous, infection-associated chronic condition present for at least 3 months after SARS-CoV-2 infection. Author Leora Horwitz, MD, MHS, of NYU Grossman School of Medicine joins JAMA Executive Editor Gregory Curfman...
2024-12-13	Camrelizumab vs Placebo With Chemotherapy as Neoadjuvant Treatment in Triple-Negative Breast Cancer Triple-negative breast cancer accounts for around 15% of breast cancers. Zhi-Ming Shao, MD, of Fudon University, joins JAMA Oncology Editor in Chief and JAMA Deputy Editor Nora Disis, MD, to discuss "Camrelizumab vs Placebo in Combination With Chemothe...